NanoEntek Balance Sheet Health
Financial Health criteria checks 6/6
NanoEntek has a total shareholder equity of ₩72.0B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩78.6B and ₩6.7B respectively. NanoEntek's EBIT is ₩955.9M making its interest coverage ratio -1.3. It has cash and short-term investments of ₩35.8B.
Key information
0%
Debt to equity ratio
₩0
Debt
Interest coverage ratio | -1.3x |
Cash | ₩35.78b |
Equity | ₩71.96b |
Total liabilities | ₩6.67b |
Total assets | ₩78.63b |
Recent financial health updates
No updates
Recent updates
Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%
Oct 10NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors
Aug 06NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Mar 21Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 14If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns
Jan 26Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)
Jan 04NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 14Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 23Financial Position Analysis
Short Term Liabilities: A039860's short term assets (₩57.8B) exceed its short term liabilities (₩5.5B).
Long Term Liabilities: A039860's short term assets (₩57.8B) exceed its long term liabilities (₩1.1B).
Debt to Equity History and Analysis
Debt Level: A039860 is debt free.
Reducing Debt: A039860 has no debt compared to 5 years ago when its debt to equity ratio was 3.4%.
Debt Coverage: A039860 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A039860 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 15:03 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NanoEntek, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
In Pil Kim | Cape Investment & Securities Co., Ltd. |
Seung-Ho Lee | iM Securities |
NaYeon Kim | Mirae Asset Securities Co., Ltd. |